[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.75.176. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 4, 1985

β2-Microglobulin and the Acquired Immunodeficiency Syndrome in a Low-Incidence Area

Author Affiliations

Tufts University School of Medicine Boston

JAMA. 1985;253(1):43-44. doi:10.1001/jama.1985.03350250051019
Abstract

To the Editor.—  The article by Zolla-Pazner et al1 impressively demonstrates the value of a simple determination—β2M in serum—as a useful adjunct to the diagnosis of AIDS and for evaluating early suspected cases and members of populations at risk. The authors point out that increased serum β2M levels are by no means specific to AIDS and can be found in various other diseases, notably autoimmune diseases and viral infections. However, they fail to consider the possible significance of interferon, levels of which often are increased in these conditions as well2,3 and may be causally related to the elevated β2M levels observed.Interferons are now known to have varied and extensive immunomodulatory effects. Important among them is a marked and rapid increase of the surface histocompatibility antigens and of their subunit—the β2M.4 β2-Microglobulin has been shown to increase

×